Related Experiment Video
Updated: Aug 16, 2026

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
De-differentiation-derived mesenchymal stem cells demonstrate selective repression in H19 bioregulatory RNA gene
Robert E Scott1, Sizhi Gao, Chung-Kwan Kim
1Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Rm. 514 Link Building, 855 Monroe, Memphis, TN 38163, USA. rescott@utmem.edu
Abstract:
Cellular de-differentiation can induce anticancer activity that makes cells resistant to carcinogenesis, but the molecular mechanism of this phenomenon has not been defined. To determine whether stable molecular changes develop in association with the process of de-differentiation, DNA microarray analyses were performed. These analyses compared control undifferentiated cells with three carcinogenesis-resistant clones of de-differentiated cells that were derived from mature adipocytes. The results of analysis of 6,000 genes and 6,000 ESTs establish that relative to control cells, all three de-differentiation-derived cell clones demonstrate that only one gene shows a consistent difference in expression. The expression of the H19 bioregulatory RNA is repressed an average of >fourfold in all de-differentiated cell clones. Real-time PCR analyses confirm these findings. This suggests that decreased H19 expression may account, at least in part, for the anticancer activity observed in de-differentiated cell clones.
Insights
Cellular de-differentiation confers anticancer activity by repressing H19 RNA expression. This molecular change in de-differentiated cells may explain their resistance to carcinogenesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Cellular de-differentiation is linked to anticancer activity and resistance to carcinogenesis.
- The precise molecular mechanisms underlying this phenomenon remain largely undefined.
Purpose of the Study:
- To investigate stable molecular alterations associated with cellular de-differentiation.
- To identify specific genes or pathways involved in the anticancer effects of de-differentiated cells.
Main Methods:
- DNA microarray analysis of 6,000 genes and 6,000 ESTs comparing control undifferentiated cells with de-differentiated adipocyte-derived clones.
- Real-time PCR to validate gene expression changes.
Main Results:
- A consistent, significant difference in gene expression was observed in de-differentiated cells compared to controls.
- The expression of H19 (a bioregulatory RNA) was repressed more than fourfold in all three de-differentiated cell clones.
Conclusions:
- Decreased expression of H19 RNA is a stable molecular change associated with cellular de-differentiation.
- Reduced H19 expression may contribute to the observed anticancer activity and carcinogenesis resistance in de-differentiated cells.
More Related Videos
06:24Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells
Published on: October 20, 2023
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
Related Concept Videos
Master Transcription Regulators
Mesenchymal Stem Cells
Maintenance of the ES Cell State
MicroRNAs
MicroRNAs
Regulation of Expression at Multiple Steps